Focus: Market Access Policy, Value & Access
In her 7+ years at Dolon, Emilie has built deep expertise at the intersection of product-level strategy and market access policy. She specialises in strategy development, haematology (particularly Multiple Myeloma), and Joint Clinical Assessment.
Before joining Dolon, Emilie completed a BSc in Biology in the United States and a MSc in Health Policy at the London School of Economics.
